Faculty Opinions recommendation of A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate.

2007 ◽  
Author(s):  
Henry Burger
Keyword(s):  
Efficacy And Safety ◽  
Safety Study ◽  
Testosterone Undecanoate ◽  
Long Acting

A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate

2007 ◽  
Vol 10 (3) ◽  
pp. 155-158 ◽  
Author(s):  
T. Minnemann ◽  
M. Schubert ◽  
T. Minnemann ◽  
M. Schubert ◽  
D. Hübler ◽  
...  
Keyword(s):  
Efficacy And Safety ◽  
Safety Study ◽  
Testosterone Undecanoate ◽  
Long Acting

Safety Study of Long-Acting Parenteral Testosterone Undecanoate over 42 Months.

2010 ◽  
pp. P2-450-P2-450
Author(s):  
F Saad ◽  
A Haider ◽  
AA Yassin ◽  
LJ Gooren
Keyword(s):  
Safety Study ◽  
Testosterone Undecanoate ◽  
Long Acting

Safety study of long-acting parenteral testosterone undecanoate over 42 months

2010 ◽  
Vol 7 (3) ◽  
pp. 341-341
Author(s):  
Ahmad Haider ◽  
Aksam A. Yassin ◽  
Louis Gooren
Keyword(s):  
Safety Study ◽  
Testosterone Undecanoate ◽  
Long Acting

scholarly journals Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men

2012 ◽  
Vol 9 (4) ◽  
pp. 10-13
Author(s):  
R V Rozhivanov
Keyword(s):  
Metabolic Syndrome ◽  
Side Effects ◽  
Sexual Function ◽  
Body Fat ◽  
Clinical Studies ◽  
Efficacy And Safety ◽  
Testosterone Undecanoate ◽  
The Metabolic Syndrome ◽  
Number Of Patients ◽  
Long Acting

The article presents the results of clinical studies on the efficacy and safety of androgen therapy for metabolic syndrome and obesity in men with hypogonadism. The study is focused on the use of testosterone undecanoate for reduction of body fat and the severity of other components of the metabolic syndrome, improvement of sexual function without causing severe side effects. In a number of patients treated we observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation.

Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study

2013 ◽  
Vol 111 (7) ◽  
pp. 1130-1140 ◽  
Author(s):  
Wei Shen Tan ◽  
Wah Yun Low ◽  
Chirk Jenn Ng ◽  
Wei Keith Tan ◽  
Seng Fah Tong ◽  
...  
Keyword(s):  
Controlled Study ◽  
Efficacy And Safety ◽  
Testosterone Undecanoate ◽  
Randomised Controlled Study ◽  
Aging Men ◽  
Long Acting ◽  
Randomised Controlled

scholarly journals Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men

2013 ◽  
Vol 10 (1) ◽  
pp. 43-46
Author(s):  
R V Rozhivanov
Keyword(s):  
Metabolic Syndrome ◽  
Side Effects ◽  
Sexual Function ◽  
The Other ◽  
Efficacy And Safety ◽  
Testosterone Undecanoate ◽  
Reduced Body ◽  
The Metabolic Syndrome ◽  
Number Of Patients ◽  
Long Acting

The paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improved sexual function without causing severe side effects. A number of patients on therapy observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation.

Efficacy and safety of long-acting pasireotide in acromegalic patients in the real life: The reappraisal of the first-dose follow-up visit

2020 ◽  
Author(s):  
Claudio Urbani ◽  
Francesca Dassie ◽  
Benedetta Zampetti ◽  
Di Certo Agostino Maria ◽  
Renato Cozzi ◽  
...  
Keyword(s):  
Real Life ◽  
Efficacy And Safety ◽  
The Real ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document